{
    "pubmed_id": 35839768,
    "study_identifier": "PMID35839768_study-01",
    "study_name": "Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19",
    "publication_title": "Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19",
    "study_objective": "To determine clinically relevant insights into the status of patient\u2019s immune responses during SARS-CoV-2 infection and to provide promising severity-specific biological signatures for future validation that may inform decision-making on potential therapeutic targets for the prevention of disease progression.",
    "study_description": "The biological determinants underlying the range of coronavirus 2019 (COVID-19) clinical manifestations are not fully understood. Here, over 1,400 plasma proteins and 2,600 single-cell immune features comprising cell phenotype, endogenous signaling activity, and signaling responses to inflammatory ligands are cross-sectionally assessed in peripheral blood from 97 patients with mild, moderate, and severe COVID-19 and 40 uninfected patients. Using an integrated computational approach to analyze the combined plasma and single-cell proteomic data, we identify and independently validate a multi-variate model classifying COVID-19 severity (multi-class area under the curve [AUC]training = 0.799, p = 4.2e-6; multi-class AUCvalidation = 0.773, p = 7.7e-6). Examination of informative model features reveals biological signatures of COVID-19 severity, including the dysregulation of JAK/STAT, MAPK/mTOR, and nuclear factor \u03baB (NF-\u03baB) immune signaling networks in addition to recapitulating known hallmarks of COVID-19. These results provide a set of early determinants of COVID-19 severity that may point to therapeutic targets for prevention and/or treatment of COVID-19 progression.",
    "primary_institution_name": "Stanford University School of Medicine",
    "study_personnel": [
        {
            "personnel_id": "PMID35839768_personnel-01",
            "honorific": "",
            "last_name": "Boyd",
            "first_name": "Scott",
            "suffixes": "",
            "organization": "Stanford University School of Medicine",
            "orchid_id": "",
            "email": "sboyd1@standord.edu",
            "seronet_title_in_study": "SeroNet Investigator",
            "role_in_study": "Investigator",
            "site_name": "Stanford University School of Medicine"
        }
    ],
    "study_file": [
        {
            "study_file_name": "PMID35839768_mmc1.pdf",
            "study_file_description": "Supplemetary data",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "PMID35839768_mmc2.xlsx",
            "study_file_description": "Supplemetary data",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "PMID35839768_mmc3.xlsx",
            "study_file_description": "Antigens",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "PMID35839768_mmc4.xlsx",
            "study_file_description": "Correlation of sMERTK levels and available markers of monocyte activation",
            "study_file_type": "Assessment Results"
        },
        {
            "study_file_name": "PMID35839768_Correlation_matrix.xlsx",
            "study_file_description": "Spearman Correlation Matrix",
            "study_file_type": "Assessment Results"
        },
        {
            "study_file_name": "PMID35839768_CyTOF_FrequencySignaling_preprocessed.xlsx",
            "study_file_description": "CyTOF Frequency Signaling",
            "study_file_type": "Assessment Results"
        },
        {
            "study_file_name": "PMID35839768_Olink_NPXvalues.xlsx",
            "study_file_description": "Olink NPX values",
            "study_file_type": "Assessment Results"
        },
        {
            "study_file_name": "PMID35839768_PatientCharacteristics.xlsx",
            "study_file_description": "Patient characteristics",
            "study_file_type": "Demographics"
        },
        {
            "study_file_name": "PMID35839768_Penalization_matrix.xlsx",
            "study_file_description": "Penalization matrix",
            "study_file_type": "Assessment Results"
        },
        {
            "study_file_name": "PMID35839768_v1.2.5.xlsm",
            "study_file_description": "Completed curation of the study into SeroNet Registry Template which includes SeroNet Study Descriptors.",
            "study_file_type": "Study Summary Description"
        },
        {
            "study_file_name": "PMID35839768_JSON.json",
            "study_file_description": "JSON format of completed curation of the study into SeroNet Registry Template which includes SeroNet Study Descriptors",
            "study_file_type": "Study Summary Description"
        }
    ],
    "study_link": [
        {
            "link_name": "Dryad",
            "value": "https://doi.org/10.5061/dryad.9cnp5hqmn"
        },
        {
            "link_name": "Github",
            "value": "https://github.com/julienhed/COVID-Severity"
        },
        {
            "link_name": "Mendeley Data",
            "value": "https://data.mendeley.com/datasets/xss9pdtc4f/1"
        },
        {
            "link_name": "Additional information ",
            "value": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238057/#sec4.2.1"
        }
    ],
    "research_focus": "Infection Response",
    "study_type": "Clinical Research",
    "keyword": [
        "Mass cytometry",
        "SARS-CoV-2",
        "COVID-19",
        "proteomics",
        "Olink",
        "stacked generalization",
        "CyTOF",
        "immunophenotyping",
        "PBMC",
        "phosphosignaling response"
    ],
    "clinical_study_design": "Cross-sectional Study",
    "in_silico_model_type": "",
    "protocol": {
        "protocol_id": "PMID35839768_protocol-01",
        "protocol_file_name": "PMID35839768_protocol-01.txt",
        "protocol_name": "PMID35839768_protocol-01",
        "protocol_description": "Study Protocol",
        "protocol_type": "Study Protocol"
    },
    "reported_health_condition": [
        "Covid-19"
    ],
    "sars_cov_2_vaccine_type": [
        "N/A"
    ],
    "clinical_outcome_measure": "Immune pathogenesis across the spectrum of COVID-19 severity",
    "enrollment_start_date": "2020-03-01",
    "enrollment_end_date": "2020-06-01",
    "number_of_study_subjects": 137,
    "age_unit": "Years",
    "minimum_age": 19,
    "maximum_age": 78,
    "study_human_cohort": [
        {
            "arm_id": "PMID35839768_human_subject-01",
            "arm_name": "Patients with mild COVID-19 infection",
            "study_population_description": "50 patients with asymptomatic or mild COVID-19 infection",
            "arm_type": "Observational",
            "ethnicity": [
                "Hispanic or Latino",
                "Not Hispanic or Latino",
                "Not Specified"
            ],
            "race": [
                "Asian",
                "White",
                "Black or African American",
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [
                "assessment_recorded_pv"
            ],
            "study_location": [
                "US: California"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Acute COVID-19 (< 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [
                "Self Reported"
            ],
            "assessment_demographic_data_types_collected": [
                "Gender"
            ],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [
                "n/a"
            ],
            "covid_19_disease_severity": [
                "Mild"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35839768_human_subject-02",
            "arm_name": "Patients with moderate COVID-19 infection",
            "study_population_description": "21 patients with moderate COVID-19 infection",
            "arm_type": "Observational",
            "ethnicity": [
                "Hispanic or Latino",
                "Not Hispanic or Latino",
                "Not Specified"
            ],
            "race": [
                "Asian",
                "White",
                "Multiracial",
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [
                "assessment_recorded_pv"
            ],
            "study_location": [
                "US: California"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Acute COVID-19 (< 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [
                "Self Reported"
            ],
            "assessment_demographic_data_types_collected": [
                "Gender"
            ],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [
                "n/a"
            ],
            "covid_19_disease_severity": [
                "Moderate"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35839768_human_subject-03",
            "arm_name": "Patients with severe COVID-19 infection",
            "study_population_description": "26 patients with severe COVID-19 infection",
            "arm_type": "Observational",
            "ethnicity": [
                "Hispanic or Latino",
                "Not Hispanic or Latino",
                "Not Specified"
            ],
            "race": [
                "Asian",
                "White",
                "Black or African American",
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [
                "assessment_recorded_pv"
            ],
            "study_location": [
                "US: California"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Acute COVID-19 (< 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [
                "Self Reported"
            ],
            "assessment_demographic_data_types_collected": [
                "Gender"
            ],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [
                "n/a"
            ],
            "covid_19_disease_severity": [
                "Severe"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35839768_human_subject-04",
            "arm_name": "Healthy controls",
            "study_population_description": "40 uninfected healthy controls",
            "arm_type": "Healthy Control",
            "ethnicity": [
                "Not Hispanic or Latino",
                "Not Specified"
            ],
            "race": [
                "Asian",
                "White",
                "Black or African American",
                "Multiracial",
                "Other Race",
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [
                "assessment_recorded_pv"
            ],
            "study_location": [
                "US: California"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "n/a"
            ],
            "assessment_clinical_and_demographic_data_provenance": [
                "Directly Measured"
            ],
            "assessment_demographic_data_types_collected": [
                "Gender"
            ],
            "sars_cov_2_history": [
                "Uninfected"
            ],
            "sars_cov_2_vaccine_type": [
                "n/a"
            ],
            "covid_19_disease_severity": [
                "n/a"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        }
    ],
    "study_model_cohort": [],
    "planned_visit": [
        {
            "visit_id": "PMID35839768_visit-01",
            "visit_name": "Blood sample collected from the COVID-19 patients and controls",
            "visit_order_number": 1,
            "visit_min_start_day": 1,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        }
    ],
    "experiment": [
        {
            "arm_id": [
                "PMID35839768_human_subject-01 | PMID35839768_human_subject-02 | PMID35839768_human_subject-03 | PMID35839768_human_subject-04"
            ],
            "associated_first_planned_visit_id": [
                "PMID35839768_visit-01"
            ],
            "assay_type": "PCR",
            "experiment_name": "PCR",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Blood"
            ],
            "biospecimen_collection_point": [
                "Post-symptom onset"
            ],
            "sars_cov_2_antigen": [],
            "assay_use": "",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [
                "SARS-Cov-2"
            ],
            "antibody_isotype": [],
            "reporting_units": "",
            "assay_reporting_format": "Quantitative"
        },
        {
            "arm_id": [
                "PMID35839768_human_subject-01 | PMID35839768_human_subject-02 | PMID35839768_human_subject-03 | PMID35839768_human_subject-04"
            ],
            "associated_first_planned_visit_id": [
                "PMID35839768_visit-01"
            ],
            "assay_type": "CyTOF",
            "experiment_name": "Mass cytometry",
            "experiment_results_file_name": "PMID35839768_CyTOF_FrequencySignaling_preprocessed.xlsx",
            "biospecimen_type": [
                "Peripheral Blood Mononuclear Cell (PBMC)"
            ],
            "biospecimen_collection_point": [
                "Post-symptom onset"
            ],
            "sars_cov_2_antigen": [],
            "assay_use": "",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [
                "SARS-Cov-2"
            ],
            "antibody_isotype": [],
            "reporting_units": "",
            "assay_reporting_format": "Quantitative"
        },
        {
            "arm_id": [
                "PMID35839768_human_subject-01 | PMID35839768_human_subject-02 | PMID35839768_human_subject-03 | PMID35839768_human_subject-04"
            ],
            "associated_first_planned_visit_id": [
                "PMID35839768_visit-01"
            ],
            "assay_type": "Multiplex Immunoassay",
            "experiment_name": "Olink multiplex proximity extension assay",
            "experiment_results_file_name": "PMID35839768_Olink_NPXvalues.xlsx",
            "biospecimen_type": [
                "Plasma"
            ],
            "biospecimen_collection_point": [
                "Post-symptom onset"
            ],
            "sars_cov_2_antigen": [],
            "assay_use": "",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [
                "SARS-Cov-2"
            ],
            "antibody_isotype": [],
            "reporting_units": "",
            "assay_reporting_format": "Quantitative"
        }
    ],
    "geriatric_subjects": "Yes",
    "pediatric_subjects": "No",
    "pregnant_subjects": "No",
    "sars_cov_2_antibodies_measured": "Yes",
    "survey_instrument_shared": "Not Specified",
    "who_disease_severity_scale_used": "Yes",
    "inclusion_exclusion": [
        {
            "inclusion_exculusion_id": "PMID35839768_inexcl-01",
            "inclusion_criterion": "Geriatric subjects",
            "inclusion_criterion_category": "inclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35839768_inexcl-02",
            "inclusion_criterion": "SARS-CoV-2 Antibodies Measured",
            "inclusion_criterion_category": "inclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35839768_inexcl-03",
            "inclusion_criterion": "WHO disease severity scale used",
            "inclusion_criterion_category": "inclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35839768_inexcl-04",
            "inclusion_criterion": "Pediatric subjects",
            "inclusion_criterion_category": "exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35839768_inexcl-05",
            "inclusion_criterion": "Pregnant subjects",
            "inclusion_criterion_category": "exclusion"
        }
    ]
}
